Menu
Sign In Pricing Add Podcast

BackTable Urology

Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay

829.797 - 848.786 Aditya Bagrodia

It might be, all right, you know, you're high risk, let's really try to get a year in and, you know, we can horse trade after that. Okay. So, yeah, you kind of mentioned, you know, there's injections, there's Degrelix, Erigolix, there's good old-fashioned ADT. Antiandrogens, do those have much of a role anymore?

0
💬 0

Comments

There are no comments yet.

Log in to comment.